Symptoms of SARS-CoV-2 infection and vaccine status of sixty-seven adult patients affected by inherited metabolic diseases: a phone survey.

Lucia BrodosiMichele StecchiDorina MitaFrancesca MarchignoliValeria GuarneriGiulio AgnelliValentino OstiFederica PerazzaFederica SacilottoAndrea PessionLoris Pironi

Published in: Orphanet journal of rare diseases (2023)

The data indicate that IMD patients adhered to the vaccination campaign comparably to the general Italian population. Adverse events to the vaccine were negligible. SARS-CoV-2 infection, which occurred in most cases after receiving at least two doses of the vaccine, did not cause serious symptoms and never required hospitalisation. A non-negligible share of patients suffered from long-Covid symptoms.

Keyphrases

electronic health record
end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
coronavirus disease
peritoneal dialysis
sleep quality
respiratory syndrome coronavirus
physical activity
patient reported outcomes
big data
patient reported